Total Payments
$244,805
2024 Payments
$6,685
Companies
49
Transactions
935
Medicare Patients
16,765
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$199,223 (81.4%)
Food & Beverage$25,865 (10.6%)
Consulting$10,200 (4.2%)
Travel$9,209 (3.8%)
Education$307.70 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $199,185 | 87 | 81.4% |
| Food and Beverage | $25,865 | 762 | 10.6% |
| Consulting Fee | $10,200 | 7 | 4.2% |
| Travel and Lodging | $9,209 | 64 | 3.8% |
| Education | $307.70 | 14 | 0.1% |
| Entertainment | $38.10 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $70,315 | 200 | $0 (2024) |
| Amarin Pharma Inc. | $60,447 | 99 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $56,680 | 127 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $21,069 | 58 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $12,621 | 38 | $0 (2024) |
| Itamar Medical Inc | $9,749 | 7 | $0 (2024) |
| Abbott Laboratories | $5,074 | 59 | $0 (2024) |
| PFIZER INC. | $947.40 | 51 | $0 (2024) |
| ABIOMED | $689.28 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $603.05 | 26 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,685 | 83 | Itamar Medical Inc ($3,091) |
| 2023 | $11,784 | 134 | Itamar Medical Inc ($3,381) |
| 2022 | $15,526 | 107 | E.R. Squibb & Sons, L.L.C. ($9,280) |
| 2021 | $2,309 | 71 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($841.91) |
| 2020 | $17,530 | 49 | Amarin Pharma Inc. ($10,203) |
| 2019 | $49,261 | 126 | Janssen Pharmaceuticals, Inc ($20,889) |
| 2018 | $64,712 | 167 | Novartis Pharmaceuticals Corporation ($20,675) |
| 2017 | $76,997 | 198 | Novartis Pharmaceuticals Corporation ($42,419) |
All Payment Transactions
935 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Heart Failure | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Heart Failure | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $87.07 | General |
| Category: Sleep Apnea testing | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/17/2024 | PROCYRION, INC. | AORTIX SYSTEM (Device) | Food and Beverage | In-kind items and services | $34.48 | General |
| Category: CARDIAC ARRHYTHMIAS AND HEART FAILURE | ||||||
| 09/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $150.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $31.27 | General |
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.11 | General |
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/26/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 43 | 4,207 | 6,125 | $1.4M | $299,599 |
| 2022 | 38 | 4,320 | 6,549 | $1.2M | $317,932 |
| 2021 | 38 | 4,167 | 6,367 | $963,195 | $317,374 |
| 2020 | 38 | 4,071 | 6,322 | $882,114 | $286,811 |
Total Patients
16,765
Total Services
25,363
Medicare Billing
$1.2M
Procedure Codes
168
All Medicare Procedures & Services
168 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 523 | 763 | $181,762 | $66,248 | 36.4% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 35 | 35 | $170,401 | $35,760 | 21.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 206 | 494 | $91,978 | $29,581 | 32.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 53 | 53 | $84,736 | $17,262 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 279 | 295 | $49,690 | $17,249 | 34.7% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 35 | 42 | $35,548 | $12,719 | 35.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 103 | 103 | $75,084 | $12,478 | 16.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 68 | 272 | $58,486 | $12,223 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 87 | 160 | $38,115 | $10,877 | 28.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 70 | 77 | $39,846 | $10,036 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 46 | 77 | $25,820 | $7,991 | 30.9% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 51 | 189 | $26,868 | $5,594 | 20.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 429 | 620 | $10,540 | $5,175 | 49.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 384 | 465 | $23,896 | $4,723 | 19.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 86 | 93 | $24,121 | $4,661 | 19.3% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 270 | 572 | $23,406 | $4,385 | 18.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 87 | 87 | $22,404 | $4,243 | 18.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 52 | 52 | $20,433 | $4,172 | 20.4% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Facility | 2023 | 113 | 113 | $146,224 | $4,169 | 2.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $9,905 | $3,547 | 35.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 412 | 515 | $15,450 | $3,177 | 20.6% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 18 | 18 | $15,450 | $3,003 | 19.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $8,494 | $2,992 | 35.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 52 | 54 | $31,766 | $2,793 | 8.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $4,695 | $1,919 | 40.9% |
About Dr. David Rawitscher, MD
Dr. David Rawitscher, MD is a Cardiovascular Disease healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700873247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Rawitscher, MD has received a total of $244,805 in payments from pharmaceutical and medical device companies, with $6,685 received in 2024. These payments were reported across 935 transactions from 49 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($199,185).
As a Medicare-enrolled provider, Rawitscher has provided services to 16,765 Medicare beneficiaries, totaling 25,363 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 168 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Plano, TX
- Active Since 09/30/2005
- Last Updated 06/22/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1700873247
Products in Payments
- ENTRESTO (Drug) $67,034
- Vascepa (Drug) $60,447
- XARELTO (Drug) $56,791
- LifeVest (Device) $21,069
- CAMZYOS (Drug) $9,730
- WatchPATONE (Device) $6,472
- WatchPAT (Device) $3,277
- CARDIOMEMS (Device) $1,615
- Circulatory Support (Device) $1,402
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $1,173
- ELIQUIS (Drug) $858.47
- Impella (Device) $689.28
- VERQUVO (Drug) $591.42
- ONPATTRO (Drug) $471.93
- JARDIANCE (Drug) $440.66
- LEQVIO (Drug) $414.60
- Repatha (Biological) $360.15
- HeartMate 3 Left Ventricular Dev (Device) $344.62
- LEXISCAN (Drug) $313.57
- HeartMate 3 Left Ventricular Assist Device (Device) $289.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Plano
Srinivasa Potluri, Md, MD
Cardiovascular Disease — Payments: $783,265
Cardiovascular Disease $783,265
Dr. David Brown, M.d, M.D
Cardiovascular Disease — Payments: $256,750
Cardiovascular Disease $256,750
Sahil Bakshi, Do, DO
Cardiovascular Disease — Payments: $193,440
Cardiovascular Disease $193,440
Mordecai Klein, Md, MD
Cardiovascular Disease — Payments: $162,433
Cardiovascular Disease $162,433
Dr. Vijay Ramanath, M.d, M.D
Cardiovascular Disease — Payments: $123,142
Cardiovascular Disease $123,142
Marc Shalek, Md, MD
Cardiovascular Disease — Payments: $106,177
Cardiovascular Disease $106,177